BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pu Y, Ji Q. Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression. Front Immunol 2022;13:874589. [PMID: 35592338 DOI: 10.3389/fimmu.2022.874589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sudhakaran M, Doseff AI. Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape. IJMS 2023;24:5086. [DOI: 10.3390/ijms24065086] [Reference Citation Analysis]
2 Zhang C, Wang L, Xu C, Xu H, Wu Y. Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1079924] [Reference Citation Analysis]
3 Zhu X, Fang Y, Chen Y, Chen Y, Hong W, Wei W, Tu J. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma. Life Sci 2023;320:121558. [PMID: 36889666 DOI: 10.1016/j.lfs.2023.121558] [Reference Citation Analysis]
4 Bi W, Guo W, Wan T, Fan G, Jiang C. Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer.. [DOI: 10.21203/rs.3.rs-2525120/v1] [Reference Citation Analysis]
5 Kohlhepp MS, Liu H, Tacke F, Guillot A. The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer-Challenges and opportunities. Front Mol Biosci 2023;10:1129831. [PMID: 36845555 DOI: 10.3389/fmolb.2023.1129831] [Reference Citation Analysis]
6 Yang Y, Cai Z, Huang K, Li M, Wang X, Lin Y, Chen S, Yang Z, Lin Z. A composite score based on immune-related gene prognostic index and m(6)A risk score of head and neck squamous cell carcinoma. Front Genet 2023;14:1061569. [PMID: 36845378 DOI: 10.3389/fgene.2023.1061569] [Reference Citation Analysis]
7 Zhao F, Tian H, Wang Y, Zhang J, Liu F, Fu L. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma. Cancer Immunol Immunother 2023. [PMID: 36688997 DOI: 10.1007/s00262-022-03364-5] [Reference Citation Analysis]
8 Xiang X, Guo F, Li G, Ma L, Zhu X, Abdulla Z, Li J, Zhang J, Huang M. Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study. Front Oncol 2022;12:1015962. [PMID: 36686751 DOI: 10.3389/fonc.2022.1015962] [Reference Citation Analysis]
9 Domingos-Pereira S, Sathiyanadan K, Polak L, Haefliger JA, Schmittnaegel M, Ries CH, Jichlinski P, Roth B, Derré L, Nardelli-Haefliger D. Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies. Int J Mol Sci 2022;24. [PMID: 36613562 DOI: 10.3390/ijms24010123] [Reference Citation Analysis]
10 Wang NH, Lei Z, Yang HN, Tang Z, Yang MQ, Wang Y, Sui JD, Wu YZ. Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review. Ann Transl Med 2022;10:1406. [PMID: 36660640 DOI: 10.21037/atm-22-6049] [Reference Citation Analysis]
11 Murugan D, Murugesan V, Panchapakesan B, Rangasamy L. Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy. Cancers 2022;14:5438. [DOI: 10.3390/cancers14215438] [Reference Citation Analysis]
12 Huang A, Lv B, Zhang Y, Yang J, Li J, Li C, Yu Z, Xia J. Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer. Front Mol Biosci 2022;9:983840. [DOI: 10.3389/fmolb.2022.983840] [Reference Citation Analysis]
13 Yang Y, Lin Z, Cai Z, Huang K, Li M, Wang X, Lin Y, Chen S, Yang Z. A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma.. [DOI: 10.21203/rs.3.rs-1987322/v1] [Reference Citation Analysis]
14 Aguilar-cazares D, Chavez-dominguez R, Marroquin-muciño M, Perez-medina M, Benito-lopez JJ, Camarena A, Rumbo-nava U, Lopez-gonzalez JS. The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. Front Endocrinol 2022;13:929572. [DOI: 10.3389/fendo.2022.929572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yamamoto T, Yamamoto Y, Ochiya T. Extracellular vesicle-mediated immunoregulation in cancer. Int J Hematol 2022. [PMID: 35951282 DOI: 10.1007/s12185-022-03436-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Aghamajidi A, Maleki Vareki S. The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer. Cancers 2022;14:3563. [DOI: 10.3390/cancers14153563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wen Z, Yang C, Zou D, Liu J, Wang S, Liu X, Zhang Y, Zhang Y. Pan-cancer analysis of PSAP identifies its expression and clinical relevance in gastric cancer. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154027] [Reference Citation Analysis]